Section Arrow
Quote
PDSB.NASDAQ
- PDS Biotechnology Corp
Quotes are at least 15-min delayed:2026/07/04 03:19 EDT
Regular Hours
Last
 0.8531
-0.0209 (-2.39%)
Day High 
0.909 
Prev. Close
0.874 
1-M High
1.2499 
Volume 
575.84K 
Bid
0.83
Ask
0.8988
Day Low
0.8202 
Open
0.86 
1-M Low
0.85805 
Market Cap 
48.78M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.9 
20-SMA 0.98 
50-SMA 1.06 
52-W High 1.55 
52-W Low 0.5068 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.66/-0.61
Enterprise Value
60.54M
Balance Sheet
Book Value Per Share
0.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1425+0.0277+24.13%-- 
PPCBPropanc Biopharma Inc.1.77+0.33+22.92%0PE
RXRXRecursion Pharmaceuticals3.8+0.13+3.54%-- 
IOVAIovance Biotherapeutics4.31+0.34+8.56%-- 
SLSSELLAS Life Sciences Group14.98+1.71+12.89%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.